NF-κB stimulates transcription of numerous genes implicated in IBD pathogenesis, including TNF. TNF inhibition is one of the main therapeutic options in IBD (100), leading to reduced IEC apoptosis and enhanced mucosal repair (91). The gene discussed is TNF; the disease is inflammatory bowel disease.